VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

Feb 20, 2020

Read Press Release

2019

Year End Results

Dec 31, 2019

PDF HTML

Earnings Release

Audio

Webcast

PDF HTML

10-K

ZIP XLS HTML

XBRL

Symbol

NYSE American: VNRX

Price

Change

MKT Cap

Volume

Volition is a multi-national company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream - an indication that cancer is present.

Volition's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. Volition's research and development activities are currently centred in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

Executive Leadership
Board of Directors

Cameron Reynolds MBA

President & Chief Executive Officer

Cameron is an experienced entrepreneurial executive, with expertise in biotechnology companies. He has extensive experience in the management, structuring, and strategic planning of start-up companies and has held positions including Chief View Full Bio

Jake Micallef PhD MBA

Chief Scientific Officer

Jake is an experienced scientist with expertise in research and development and in the management of early stage biotechnical companies, including the manufacturing of biotechnology products and the establishment of manufacturing View Full Bio

David Vanston MBA FCCA

Chief Financial Officer

David has 20 years of financial management experience. Prior to Volition and Octo Telematics, David held positions as Vice President of Excorp Medical, Inc., an early-stage company, Chief Financial Officer for GrowHow Ltd and Vice View Full Bio

Louise Batchelor

Chief Marketing and Communications Officer

Louise brings more than 20 years of marketing, sales and leadership experience to her role at Volition. Since 2011, she has served as Director and Owner of Aculd Ltd, a strategic marketing consultancy specializing in healthcare. Formerly View Full Bio

Gaetan Michel PhD

Chief Executive Officer of Belgian Volition SPRL

Gaetan has over 10 years of experience in production management. Following the completion of his PhD in 2002, Gaetan joined AAT (Advanced Array Technology), a University of Namur spin-off company as project manager in proteomics. AAT later View Full Bio

Jason Terrell MD

Chief Medical Officer & Chief Executive Officer of Volition America, Inc.

Jason has expertise in clinical medicine and in laboratory diagnostics. He was educated at Hardin-Simmon University (Biochemistry) where he graduated Summa Cum Laude, also receiving the Holland Medal of Honor. He received his Doctor of View Full Bio

Jasmine Kway PhD

Chief Executive Officer, Singapore Volition

Jasmine has a proven track record in achieving positive business results by developing strategic business alliances, identifying new markets, and developing business processes. As a thought leade in technology management and View Full Bio

Nathan Dewsbury

Chief Executive Officer of Volition Veterinary Diagnostics Development LLC

Mr. Dewsbury has global expertise in the animal health industry having direct involvement in national testing programs, current health diagnostics platforms and commercializing next generation diagnostics. He has a strong background in View Full Bio

Rod Rootsaert LLB

Corporate Secretary

Rod is an experienced legal and corporate secretary with over ten years’ experience in providing corporate, legal and administrative services to start-up companies. He previously served as corporate secretary for several junior View Full Bio

Scott Powell PhD

Executive Vice President, Investor Relations & Chief Financial Officer of Volition America, Inc.

Scott has nearly 20 years of experience in the U.S. capital markets and investor relations. Scott has served as Head of Investor Relations for four public companies, including Volition, and worked for several years as an View Full Bio

Dr. Mark Eccleston

Business Development Director

Dr Mark Eccleston is an enthusiastic and passionate biotechnology entrepreneur with over 20 years experience in the sector. He holds a PhD in Polymer Chemistry for biomedical applications and gained an MBA (entrepreneurship) from the View Full Bio

Dr. Martin C Faulkes

Chairman

Dr. Martin Faulkes has over 30 years of entrepreneurial and managerial experience as the founder and CEO of several software companies within the United Kingdom and the United States. From 1979 to 1984, Dr. Faulkes was the Founder, View Full Bio

Cameron Reynolds MBA

President & Chief Executive Officer

Dr. Phillip Barnes

Non-Executive Director

Dr. Barnes is a British physician with extensive experience both as a clinician and clinical manager within the UK National Health Service ("NHS") and related academic institutions. Dr. Barnes was also involved in a number of national and View Full Bio

Dr. Alan Colman

Non-Executive Director

Alan Colman obtained a BA degree in Biochemistry in Oxford (1971) and a PhD under John Gurdon, a pioneer of the field of nuclear transfer, at the Laboratory of Molecular Biology in Cambridge, UK (1974). After a series of academic View Full Bio

Dr. Edward Futcher

Non-Executive Director

Dr. Futcher holds a B.Sc. in Physics and a Ph.D. in Physics from the University of London and has extensive experience in engineering and management in high technology companies. Since 1997, Dr. Futcher has held non-executive View Full Bio

Guy Innes ACA

Non-Executive Director

Guy Archibald Innes is a Chartered Accountant and a member of the Institute of Chartered Accountants in England and Wales. Mr. Innes has extensive experience in financing and managing technology companies, which he gained from serving as View Full Bio

Investor Relations
VolitionRx
Scott Powell
T: (646) 650-1351
investorrelations@volition.com

Edison Advisors
Joseph Green
T: (646) 653-7030
jgreen@edisongroup.com

Edison Advisors
Rachel Carroll
T: +44 (0) 20 3077 5711
rcarroll@edisongroup.com

Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.vstocktransfer.com

Investor Relations

Latest News

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

Latest Financial Results

2019

Stock Information

Symbol

Price

Change

MKT Cap

Volume

Company Overview

Management Team

Cameron Reynolds MBA

Jake Micallef PhD MBA

David Vanston MBA FCCA

Louise Batchelor

Gaetan Michel PhD

Jason Terrell MD

Jasmine Kway PhD

Nathan Dewsbury

Rod Rootsaert LLB

Scott Powell PhD

Dr. Mark Eccleston

Dr. Martin C Faulkes

Cameron Reynolds MBA

Dr. Phillip Barnes

Dr. Alan Colman

Dr. Edward Futcher

Guy Innes ACA

IR Contact Information